Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,821.65 -2.85 -0.10%
FTSE 100 6,803.87 +48.24 0.71%
DAX 8,472.20 +16.37 0.19%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,180.06 -28.98 -0.56%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Celgene Corp

+ Add to Watchlist

CELG:US

123.5000 USD 0.3800 0.31%

As of 17:20:00 ET on 05/21/2013.

Company Profile for Celgene Corp (CELG)

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Contact Information

Celgene Corp

86 Morris Avenue
Summit, NJ 07901
United States
Phone: 1-908-673-9000

Key Executives for Celgene Corp (CELG)

Robert J HuginChairman/President/CEOJacqualyn A FouseExec VP/CFO
Perry A KarsenExec VP/COOThomas O DanielExec VP/Pres:Research
Lawrence V SteinExec VP/Secy/General CounselMark J AllesExec VP/Head:Hematology
Patrick E Flannigan IIIVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil